澳门太阳集团城网址8(中国)有限公司-百度百科

On 31st Aug. 2017, Mr. Gao Ding (director of Yancheng FDA) and guests from Yancheng FDA, Dafeng FDA and Commission of Economy and Information Technology visited Yancheng Desano pharmaceuticals Co., Ltd. Mr. Chen Fenghua (president of Yancheng Desano pharmaceuticals Co., Ltd), Mr. Xiong Yuyou(GM of Yancheng Desano pharmaceuticals Co., Ltd), Mr. Yang Chun (GM of Jiangsu Puxin pharmaceuticals Co., Ltd), Mr. Zhai Jinlu (GM of Dafeng Hegno pharmaceuticals Co., Ltd) and Mr Chen Shaogui (GM of Jiangsu Chengkang pharmaceuticals Co., Ltd) attended the meeting.

The guests visited Yancheng Desano pharmaceuticals Co., Ltd, Dafeng Hegno pharmaceuticals Co., Ltd, Jiangsu Chengkang pharmaceuticals Co., Ltd, on-site visited the QC and workshop, learned the development plan, production operation and quality management of companies.

Mr Cheng Fenghua introduced the general development condition of Yancheng Desano pharmaceuticals Co., Ltd. The postponement of the progress of project examination and approval of automation reconstruction, environmental impact assessment and safety assessment faced during the development was fully communicated by both parties. Mr Gao Ding expressed that abide by the innovative supervision method, FDA will focus on the development of the company to keep close communication with companies and timely feedback the appeals from companies to governments and corresponding departments. City and District FDA will keep close cooperation to provide policy consultation, technical support and other services about the establishment of pharmaceutical companies, application of drug manufacturing certificate to help the company well dispose the bottle-neck of development and fully support the project development of Yancheng Desano pharmaceuticals Co., Ltd.